Background: Serum albumin is routinely measured; cheap and easily available test even in remote areas laboratories. Albumin is the major protein of human plasma and one of the negative acute phase reactants reported to fall as a component of metabolic response to injury or infection, independent of the nutritional status. Even though this has also been noted in patients with head injury and its overall signifi cance with respect to neurological outcome following head injury are yet to be established. Aims and Objectives: To assess the role of serum albumin in outcome of head injury patient. Materials and Methods: This is a prospective case control study. Total 200 cases of traumatic brain injury [152 male and 48 female] were studied in NRS Medical College, Kolkata from September 2012 to October 2013. Serum albumin estimation, along with clinical and radiological data was collected. Serum albumin was compared between among various subgroups and outcome was assessed by Glasgow Coma Scale at 6 months. Results: In present study 86 (43%) patients having hypoalbuminemia (< 3.5 gm/dl) and falling trend in admission serum albumin levels from day 1 to 10 th day with decrement in GCS was statistically highly signifi cant (p < 0.001) as hypoalbuminemia was noted in 68%, 39.65 and 33.43% patients with severe, moderate and mild head injury respectively. The present study was showed that female TBI patients having less no. of hypoalbuminemia compare to male as 77.7%, 45.4%, 31.4% male and 42.8%, 28.5%, 27.2% female having hypoalbuminemia (< 3.5 gm/dl) in severe, moderate and mild head injury respectively and statistically signifi cant difference in severe and moderate group. Conclusion: The serial estimation of serum albumin in traumatic brain injury patients provides the treating doctor an insight in the prognosis of the patient so that they can be managed aggressively.
INTRODUCTION
All neurological damage does not occur at the moment of impact but evolves over the ensuing hours and days, with the primary injury initiating a secondary injury cascade, leading to deleterious pathophysiological and biochemical reactions. 1 Albumin is the major protein of human plasma and one of the negative acute phase reactants reported to fall as a component of metabolic response to injury independent of the nutritional status. 2, 3 Only a few biochemical markers have been identifi ed to prognosticate the severity of trauma at the tissue level. 4 To explore the effi cacy of albumin as a neuroprotective agent
Serial estimation of serum albumin and its role in traumatic brain injury patients
for TBI in humans, a randomized controlled trial, Albumin for Intracerebral Hemorrhage Intervention (ACHIEVE), is underway. 5 Although this issue is still controversial but in his serum albumin levels and its overall signifi cance with respect to neurological outcome following head injury are yet to be established. 2, 6, 7 Despite the volume of research in this area, only few prospective studies in literatures were found on traumatic brain injury in relation to serum albumin.
In view of the above facts, this prospective study intends to evaluate the changes in the serum albumin levels in traumatic brain injury patients and its role on neurological outcome as an independent prognostic indicator to identify who are likely to have a poor outcome.
MATERIALS AND METHODS
This is a prospective cohort study with control. Total 200 cases of traumatic brain injury along with 50 healthy controls were studied in department of Neurosurgery NRS Medical College, Kolkata from September 2012 to October 2013. Data regarding clinical and radiological status of patient were collected. Severity of traumatic brain injury was defi ned according to Glasgow Coma Scale (GCS) at admission (mild: 14-15, moderate: 9-13, and severe <9).
Exclusion criteria
1. Patients less than 12 years and more than 60years. 2. Alcoholics. 3. Poly trauma pt. 4. Hepatic diseases, chronic renal failure and patient with cardio-respiratory diseases.
Daily clinical assessment was done along with repeat CT scan brain when need. The routine blood investigation along with serum albumin estimation was done at the time of admission and on day 3, 5 and 10. The serum samples were analyzed for albumin levels by bromocresol green [BCG] dye binding method using an auto analyzer XL-600.
Standard protocol for management of head injury was given to study patients. Decision regarding surgical decompression was taken according to clinical and the computed tomography scan fi ndings. Neuro ICU care and mechanical ventilator support was given when need. Oral or nasogastric tube feeding was initiated as early as possible. Parenteral hyperalimentation or albumin supplements were not given.
We have assessed the outcome of our patients on the basis of Glasgow Outcome Scale (GOS) at 6 months. 
RESULTS
In the present study 152 (76%) male, 48 (24%) female with traumatic brain injury and 50 ages & sex matched healthy controls were studied. The incidence of head injury is more common in the 3 rd and 4 th decade with male & female ratio of (3.1:1). 24% patients of severe to moderate traumatic brain injury have contusion and 28% cases of TBI having multiple intracranial injuries (Table 1a ).
The mean age at admission is higher for unfavorable group (39.24 years) compare to favorable group (37.55 yrs) and on admission mean serum albumin levels in patients of In present study on day 1 the mean serum total protein was 6.15 (SD±0.94) g/dl and on 10 th day 6.18 (SD±0.92) g/dl. Levels showed insignifi cant (p=0.548) increase from day 1 to day 10 ( Figure 1a ).
In present study 86 (43%) patients having hypoalbuminemia (< 3.5gm/dl) (Table1c).
At 6 months unfavorable outcome in TBI patients was noticed more in the group who had admission hypoalbuminemia, as compared to those having normal levels and the difference was statistically highly signifi cant (p<0.001) (Table1d).
Although statistically insignifi cant outcome difference was observed gender wise but less no. of female patient in unfavorable group 7 (14.9%) than male 40 (85.1%) ( 88.5% patients were discharged with improved neurological status and (11.5%) were succumbed in present study with majority of them were in unfavorable group (22 among 23) (Figure 1b ). 20 male patients died in unfavorable group(40) and 2 patient in favorable group(112) and 1 female patient died in unfavorable group(7) statistically signifi cant gender wise mortality differences observed(p<0.001). (Figure 1c ).
In present study the mean duration of neuro ICU stay was 8.08 (±3.008) days and 3.84 (±2.433) days in group of albumin less than 3.5 gm/dl and more than 3.5 gm/dl respectively and difference was statistically signifi cant (p<0.001) (Figure 1d ). In our study statistically signifi cant (p=0.011) difference in the mean duration of mechanical ventilation was observed between group of hypoalbuminemia and normoalbuminemia 5.92 (±3.008) days and 3.50 (±2.433) respectively ( Figure 1d ).
This study showed that the complications like infection, delayed wound healing was higher for unfavorable group (14.9%) than in favorable group (8.5%), although the difference was statically insignifi cant (p=0.201) (Figure 1e ). 
DISCUSSION
In the present study (Table 1c) 25% severe and 75% mild to moderate head injury patients were included and the sample size was comparable with study of Du Chen, et al. 8 Dhandapani SS et al 9 and Bernard F, et al 6 were recorded serum albumin levels until day 21 after head injury. Young et al. 10 noted hypoalbuminemia to last for at least 3 weeks following traumatic brain injury. Keeping in view the above mentioned facts in the present study we have measured the serum albumin level in a traumatic brain injury patient in a serial manner. In present study (Table 1b) on admission mean serum albumin levels in patients of head injury were 3.760±0.339 g/dl as compared to control 4.214±0.186 g/dl and statistically signifi cant difference was found (p < 0.001). This fi nding is comparable with study of Dhandapani SS et al 11 where the admission mean serum albumin levels in patients of head injury were (3.24, SD ± 0.52 g/dl) as compared with the control (4.15, SD ± 0.48 g/dl).
The mean serum total protein levels was showed insignifi cant increase in the fi rst week as in the study of Dhandapani SS et al 9 which is comparable with our present study as on day 1 the mean serum total protein was 6.15 (SD±0.94) g/dl and on 10 th day 6.18(SD±0.92) g/dl, levels showed insignifi cant (p=0.548) increase (Figure 1a ). This fi nding is explained by Veldee MS et al 3 as serum total protein levels did not show signifi cant difference, possibly due to confl icting effect of increased positive acute phase reactants such as C reactive protein (CRP), á-1 acid glycoprotein & á-1 antitrypsin and decreased serum albumin levels.
Dhandapani SS et al 11 in his study was defined the hypoalbuminemia at admission when serum albumin ≤ 3.5 g/dl and there was a signifi cant falling trend in admission serum albumin levels with decrement in GCS as hypoalbuminemia which is similar to our study fi ndings.
In this study (Table 1c) it was also noted that 77.7%, 45.4%, 31.4% male and 42.8%, 28.5%, 27.2% female having hypoalbuminemia (< 3.5gm/dl) in severe, moderate and mild head injury respectively and the difference was statistically significant for severe and moderate head injury but insignifi cant in mild head injury group. The less hypoalbuminemia in our present study population in all GCS category when comparing to others studies is due to female patient having less frequent fall in albumin when comparing with others studies. Bernard F, et al 6 cohort had a outcome 70% favorable and 30% unfavorable at 6 months with 22 (16%) of them died. Like that in present study cohort 76.5% favorable outcome and 23.5% unfavorable outcome at 6 months with 23 (11.5%) of them died (Table 1d ).
Dhandapani SS et al 11 was noted unfavorable outcome at 3 months in 62% of patients having admission hypoalbuminemia, as compared to 18% of those having normal levels (p <0.001).The association of admission hypoalbuminemia with unfavorable outcome was uniform throughout all grades of head injury and the association was signifi cantly stronger in non-surgical patients. In present study unfavorable outcome at 6 months was noted in 76.6% of patients having admission hypoalbuminemia (<3.5 gm/dl), as compared to 23.4% of those having normal levels and the difference was statistically highly signifi cant (p<0.001). 26 patients were managed surgically in which 22(14.4%) patient in favorable group and 4 patients in unfavorable group (Figure 1c ) with statistically insignifi cant differences (p = 0. 295). So it is less likely that surgical patients affect results here.
In study of Dhandapani SS et al 9 the Glasgow outcome score at 6 months was available for 40 patients of GCS (4-8). The unfavorable outcome was noted in 12 out of 15 patients with at least 15% fall in serum albumin levels at 3 weeks, as compared to 11 out of 25 patients with less than 15% fall in serum albumin and the difference was statistically signifi cant. In our study (Table 2a) the unfavorable outcome was noted in 28 out of 50 patients of GCS (4-8) the fall in serum albumin from day 1 of admission to 10 th day was 17.87%.
In this study (Table 2b ) fall in serum albumin was 18.65% from day1to day10 in unfavorable group comparing to 8.63% in favorable group. These our above mentioned fi ndings were correlated with literatures as mentioned by Bernard F, et al 6 albumin levels were higher in the fi rst few days after injury in patients with a good outcome. The albumin levels decreased appreciably compared with normal values in both favorable and unfavorable groups. However, the albumin levels remained below 2.5 gm/dl for a longer period of time in the group with a bad outcome (3 days vs. 6 days; p < 0.012). Recently, Yang TJ et al 12 and colleagues performed a retrospective cohort study, and concluded that the most favorable level of albumin for uncomplicated severe TBI is 2.9-3.1 gm/dl. Taking consideration of above literatures and our study results showed that there is a steady fall in serum albumin in both groups. However the fall in unfavorable group is more steep than favorable. It suggests that the rapidity with which serum albumin level falls has an effect on the outcome and prognosis of the patient this is similar to McCluskey A et al 13 study which reports that serum albumin levels decreased more steeply in non survivors. A steep decline in serum albumin indicates a poor prognosis. Du Chen et al 8 results demonstrated, in patients of TBI with serum albumin ≥3.5 gm/dl, the proportion of unfavorable outcome was reduced signifi cantly. In our present study the proportion of unfavorable outcome was reduced highly signifi cantly (p <0.001) where serum albumin ≥3.5 gm/dl. Serum albumin levels in patients of head injury did not show signifi cant gender difference (Mean values 3.3 vs. 3 g/dl). 7 But in present study the female patients having higher mean serum albumin compare to male on all days (1,3,5,10) and statistically significant differences was observed on 10 th day (p = 0.045) (Table 2c) .
Males are more likely to suffer from a critical illness than females Blunt MC et al 14 keeping in view the literatures facts our study results also shows that in severe head injury group means critically ill where the serum albumin <3.5 gm/dl the mortality is more for male patients compare to female. Female patients having less hypoalbuminemia in both favorable and unfavorable group of TBI with less steeper fall in serum albumin from day1to day 10. This is the possible explanation of better outcome here for females suffering from TBI.
In our study (Figure 1b ) of 200 TBI patients 177 patients (88.5%) were discharged (survivors) from the hospital and 23 patients (11.5%) expired (non survivors) in the hospital similarly McCluskey A et al 13 study has reported 70% survivors and 30% non-survivors. Another study of Blunt MC et al 14 was reported 54% survivors and 46% non survivors.
In our study, (Table 2d ) mean serum albumin level on day of admission (Day 1) for the study group was 3.76 g/dl (± 0.4 gm/dl) and in survivors, it was 3.81 gm/dl (± 0.3 gm/dl) and highly signifi cantly lower (p < 0.001) in non survivors 3.35 gm/dl (± 0.6 g/dl). In the survivor group, 62.71% patients have normal serum albumin levels on admission as compared to just 8.75% in the non survivor group, suggesting hypoalbuminemia at admission indicates a poorer prognosis in terms of increased mortality. In Yap FM, et al 15 study survivors had higher admission albumin (2.57 g/dl vs 2.10 g/dl, p<0.005) than non survivors. In Banga A, et al 16 study, the mean serum albumin levels on day one were reported to be 3.2 g/dl (± 0.7 g/dl) which is comparable to our study as in present study, the mean level of serum albumin on day three in study group was 3.51 g/dl (± 0.4 gm/dl). In survivors it was 3.58 gm/dl (± 0.51 g/dl) and in non survivors it was 3.01gm/dl (± 0.22 g/dl). It was signifi cantly lower (p < 0.001) in non survivors. Banga A, et al 16 study the day three levels of serum albumin in non survivors was 2.9 g/dl (± 0.6g/dl) which is similar to our study.
The study shows here the mean duration of Neuro ICU stay and mechanical ventilation was signifi cantly higher in hypoalbuminemia group (Figure 1d ).
McCluskey A et al, 13 Blunt MC et al 14 and Nicholson JP et al 17 studies, reported that nonsurvivors had lower serum albumin concentrations on admission to the ICU, and their albumin concentrations decreased more rapidly in the fi rst 24 to 48 h. This explains the longer ICU stay of unfavorable group in our study.
Sapijaszko MJA, et al 18 studies reports that albumin concentration on ICU admission was not a predictor of Nelson DW, et al 19 and various other studies reported that low level of serum albumin seems to be an independent predictor for poor outcome of TBI. Lower level of albumin is bound to weaken the patient's resistance, resulting in slow wound healing and fragile resistance to secondary infection. Eventually, the risk of poor prognosis is signifi cantly increasing. 6, 8 Results of our study give this a further confi rmation as in our study (Figure 1e ) the complications like infection, delayed wound healing was higher for unfavorable group (14.9%) than in favorable group (8.5%).
In our study ( In the analysis of all patients, in our study (Table 3a & b) after adjustment for the effects of age, GCS both univariate and multivariate logistic regressions model determined serum albumin less than 3.5 g/dl and severity of GCS was found to be highly signifi cantly, associated with unfavorable outcome. Both factors were emerging as independent predictors for of TBI at 6 months. The our fi ndings are comparable with Dhandapani SS et al 11 Bernard F, et al 6 and Du Chen, et al. 8 Yurchenco PD et al 20 studies was explaining different mechanisms for the decline of serum albumin in patients with TBI. Firstly, albumin consumption is increased under stress state. Secondly, hemorrhage caused albumin lost. Thirdly, inadequate intake and the suppressed liver function would reduce albumin synthesis. In addition, albumin extravasation due to increased vascular permeability and blood brain barrier dysfunction. Rossi JL et al 21 and colleagues performed an experiment which explains the mechanism of reduced albumin which leads to the poor prognosis of TBI from the aspect of the blood-brain barrier integrity.
Rodling WM et al 22 and colleagues reported that a protocol including albumin administration in combination with a neutral to a slightly negative fl uid balance was associated with low mortality in patients with severe TBI. Findings from animal experiment may explain the mechanism partly. Belayev L et al 23 was observed in his experimental study, that high-concentration albumin therapy instituted 15 min after trauma signifi cantly improves the neurological score and reduces histological damage. Du Chen et al 8 recently in 2014 recommend that it would be better to maintain a moderately high level of serum albumin for patients of TBI based on his results and related studies.
Our studies results showed that there is a broad therapeutic window as the decline of serum albumin is showed from day 1 to day 10. These fi ndings were further confi rmed with the study of Dhandapani SS et al 9 in this study the nadir of serum albumin levels was noted at second week followed by partial but signifi cant restitution similar to the fi ndings of Young et al 10 and this may suggest a possible window period. Further confi rmed by Belayev L et al 24 in his study reported that albumin also has a favorable therapeutic time window allowing administration within a clinically feasible delay.
CONCLUSION
Based on our results low level of serum albumin is a risk factor for TBI, and the percentage of favorable outcome decreases with hypoalbuminemia. It would be better to maintain the level of serum albumin more than 3.5 gm/dl in traumatic brain injury patients specifi cally in severe head injury. The female patients performed better in all subgroups due to less steep fall in serum albumin. There may be a therapeutic window from day 1 to day 10.
